These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1362158)

  • 1. Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine: characterization of receptor subtypes.
    Sawynok J; Reid A
    Eur J Pharmacol; 1992 Nov; 223(1):49-56. PubMed ID: 1362158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal supersensitivity to 5-HT1, 5-HT2 and 5-HT3 receptor agonists following 5,7-dihydroxytryptamine.
    Sawynok J; Reid A
    Eur J Pharmacol; 1994 Nov; 264(3):249-57. PubMed ID: 7698162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
    Herndon JL; Pierson ME; Glennon RA
    Pharmacol Biochem Behav; 1992 Nov; 43(3):739-48. PubMed ID: 1333084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
    Alhaider AA; Wilcox GL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):378-85. PubMed ID: 7682614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
    Fone KC; Robinson AJ; Marsden CA
    Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test.
    Sasaki M; Ishizaki K; Obata H; Goto F
    Eur J Pharmacol; 2001 Jul; 424(1):45-52. PubMed ID: 11470259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord.
    Crisp T; Stafinsky JL; Spanos LJ; Uram M; Perni VC; Donepudi HB
    Gen Pharmacol; 1991; 22(2):247-51. PubMed ID: 1829046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors.
    Shannon HE; Lutz EA
    Psychopharmacology (Berl); 2000 Mar; 149(1):93-7. PubMed ID: 10789888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin is a directly-acting hyperalgesic agent in the rat.
    Taiwo YO; Levine JD
    Neuroscience; 1992; 48(2):485-90. PubMed ID: 1534874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic and purinergic involvement in spinal antinociception by 5-hydroxytryptamine and 2-methyl-5-hydroxytryptamine.
    Sawynok J; Reid A
    Eur J Pharmacol; 1991 Nov; 204(3):301-9. PubMed ID: 1663459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
    Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception.
    Sawynok J; Reid A
    Behav Brain Res; 1996; 73(1-2):63-8. PubMed ID: 8788479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach.
    Paul D; Yao D; Zhu P; Minor LD; Garcia MM
    J Pharmacol Exp Ther; 2001 Aug; 298(2):674-8. PubMed ID: 11454930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
    Matsumoto I; Combs MR; Jones DJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
    Chaouloff F; Aguerre S; Mormede P
    Neuropharmacology; 1998 Sep; 37(9):1159-67. PubMed ID: 9833646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.